When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. UVA pain research suggests new ways to manage migraine ... - AOL

   www.aol.com/uva-pain-research-suggests-ways...

   If you suffer from chronic migraines, new research suggests a ... “Blocking progesterone receptor-regulated signaling in the brain presents a promising avenue for novel migraine treatment ...

3. Migraines are getting worse — and climate change could be ...

   www.aol.com/news/migraines-getting-worse-climate...

   Researchers found the prevalence of migraines in the past three decades has remained stable, but found Migraine Disability Assessment Scale scores, which measure how migraines affect a person ...

4. New Startups and Innovations Are Starting To Give Migraine ...

   www.aol.com/startups-innovations-starting...

   Despite the prevalence of the illness, there are only about 500 headache specialists in the United States, and there’s been a lack of funding for research into causes and treatment, according to ...

5. Management of migraine - Wikipedia

   en.wikipedia.org/wiki/Management_of_migraine

   Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

6. Management of chronic headaches - Wikipedia

   en.wikipedia.org/wiki/Management_of_chronic...

   Andrasik, F. "Behavioral Treatment Approaches to Chronic Headache." Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society Of Clinical Neurophysiology 24 Suppl 2 (2003): S80-5. Buchholz, David. Heal Your Headache: The 1-2-3 Program for Taking Charge of Your Headaches. New York: Workman, 2002.

7. Antimigraine drug - Wikipedia

   en.wikipedia.org/wiki/Antimigraine_drug

   It is theorized that by antagonizing the CGRP receptor of the trigeminal ganglia, lowered CGRP is released and less migraine occurs. [14] Erenumab is a highly selective human monoclonal antibody which is a promising new development in migraine treatment. [14]